These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37629363)

  • 21. Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer.
    Leapman MS; Wang ZJ; Behr SC; Kurhanewicz J; Zagoria RJ; Carroll PR; Westphalen AC
    Radiol Bras; 2017; 50(5):299-307. PubMed ID: 29085163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative analysis of techniques for measuring tumor contact length in predicting extraprostatic extension.
    Asfuroğlu U; Asfuroğlu BB; Özer H; İnan MA; Uçar M
    Eur J Radiol; 2024 Sep; 181():111753. PubMed ID: 39357285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging classification of prostate cancer with extracapsular extension and its impact on positive surgical margins after laparoscopic radical prostatectomy.
    Wang JG; Zhong C; Zhang KC; Chen JB
    Front Oncol; 2024; 14():1344050. PubMed ID: 38511144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
    J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraprostatic extension in prostate cancer: primer for radiologists.
    Shieh AC; Guler E; Ojili V; Paspulati RM; Elliott R; Ramaiya NH; Tirumani SH
    Abdom Radiol (NY); 2020 Dec; 45(12):4040-4051. PubMed ID: 32390076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation analysis between prostate imaging report and data system score and pathological results of prostate cancer].
    Zhu LY; Ding XF; Huang TB; Luan Y; Guo CH; Xu YZ; Wang F
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2663-2668. PubMed ID: 32921014
    [No Abstract]   [Full Text] [Related]  

  • 27. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
    Deniffel D; Healy GM; Dong X; Ghai S; Salinas-Miranda E; Fleshner N; Hamilton R; Kulkarni G; Toi A; van der Kwast T; Zlotta A; Finelli A; Perlis N; Haider MA
    Radiology; 2021 Aug; 300(2):369-379. PubMed ID: 34032510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Park KJ; Kim MH; Kim JK
    Radiology; 2020 Jul; 296(1):87-95. PubMed ID: 32368959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
    Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of T2-weighted images in assessing the grade of extraprostatic extension of the prostate carcinoma.
    Onay A; Ertas G; Vural M; Colak E; Esen T; Bakir B
    Abdom Radiol (NY); 2020 Oct; 45(10):3293-3300. PubMed ID: 32002569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate Magnetic Resonance Imaging Analyses, Clinical Parameters, and Preoperative Nomograms in the Prediction of Extraprostatic Extension.
    Majchrzak N; Cieśliński P; Głyda M; Karmelita-Katulska K
    Clin Pract; 2021 Oct; 11(4):763-774. PubMed ID: 34698089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External Validation of a Prediction Model for Side-specific Extraprostatic Extension of Prostate Cancer at Robot-assisted Radical Prostatectomy.
    Veerman H; Heymans MW; van der Poel HG
    Eur Urol Open Sci; 2022 Mar; 37():50-52. PubMed ID: 35243390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
    Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
    BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging.
    Gatti M; Faletti R; Gentile F; Soncin E; Calleris G; Fornari A; Oderda M; Serafini A; Strazzarino GA; Vissio E; Bergamasco L; Cirillo S; Papotti MG; Gontero P; Fonio P
    Eur Radiol; 2022 Jul; 32(7):4942-4953. PubMed ID: 35290508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?
    Zhang Y; Zeng N; Zhang F; Huang Y; Tian Y
    Int J Clin Oncol; 2020 Jan; 25(1):175-186. PubMed ID: 31473884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.
    Luzzago S; Musi G; Catellani M; Russo A; Di Trapani E; Mistretta FA; Bianchi R; Cozzi G; Conti A; Pricolo P; Ferro M; Matei DV; Mirone V; Petralia G; de Cobelli O
    Urol Int; 2018; 101(1):56-64. PubMed ID: 29734177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.
    Diamand R; Roche JB; Lacetera V; Simone G; Windisch O; Benamran D; Fourcade A; Fournier G; Fiard G; Ploussard G; Roumeguère T; Peltier A; Albisinni S
    World J Urol; 2024 Apr; 42(1):247. PubMed ID: 38647728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer.
    Wibmer AG; Kattan MW; Alessandrino F; Baur ADJ; Boesen L; Franco FB; Bonekamp D; Campa R; Cash H; Catalá V; Crouzet S; Dinnoo S; Eastham J; Fennessy FM; Ghabili K; Hohenfellner M; Levi AW; Ji X; Løgager V; Margolis DJ; Moldovan PC; Panebianco V; Penzkofer T; Puech P; Radtke JP; Rouvière O; Schlemmer HP; Sprenkle PC; Tempany CM; Vilanova JC; Weinreb J; Hricak H; Shukla-Dave A
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer.
    Cao Y; Cao M; Chen Y; Yu W; Fan Y; Liu Q; Gao G; Zhao Z; Wang X; Jin J
    Oncotarget; 2017 Jul; 8(27):44040-44049. PubMed ID: 28476042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.